Celebrating the Rise of Dogecoin with Katie Miller and Trump Introduction Who would have thought that a cryptocurrency based on a meme featuring a Shiba Inu dog would become such a cultural phenomenon? Dogecoin (CRYPTO: DOGE) has taken the world by storm with its lighthearted and community-driven approach to digital currency. And just when we…
The Impact of the Securities Class Action Lawsuit Against PACS Group, Inc. Background In December 2024, the law firm of Kessler Topaz Meltzer & Check, LLP announced that a securities class action lawsuit has been filed against PACS Group, Inc. The lawsuit, filed in the United States District Court for the Southern District of New…
Investigation into AstraZeneca PLC: What Investors Need to Know Stay Informed, Stay Involved Hey there, savvy investors! Have you heard the latest news about AstraZeneca PLC? If not, allow me to fill you in on the details. Levi & Korsinsky, a well-known firm, has recently launched an investigation into AstraZeneca PLC for potential violations of…
Stran & Company Faces Nasdaq Delisting What Happened? On December 17, 2024, Stran & Company, Inc. received a letter from the Nasdaq Stock Market LLC stating that they were facing a delisting determination due to non-compliance with the Filing Rule. This rule requires companies to file quarterly reports with the SEC, which Stran had failed…
Oh No! Another Day, Another Lawsuit Have you ever bought a product that turned out to be a dud? Well, you’re not alone. It looks like investors in Applied Therapeutics, Inc. are feeling the burn as a class action lawsuit has been filed against the company and some of its officers. Ouch. What’s the scoop?…
Quoin Pharmaceuticals Ltd. Announces Pricing of Public Offering About Quoin Pharmaceuticals Ltd. Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) is a clinical stage, specialty pharmaceutical company that focuses on rare and orphan diseases. The company is dedicated to developing innovative solutions to help patients with these challenging conditions. Public Offering Details On December 20, 2024, Quoin Pharmaceuticals…
Gordon Johnson’s Beef with Bitcoin: Is it Really Rat Poison? A Closer Look at GLJ Research CEO’s Criticism Have you heard the latest drama in the world of cryptocurrency? GLJ Research CEO Gordon Johnson has intensified his criticism of Bitcoin, echoing the sentiments of the legendary Charlie Munger. But is Bitcoin really as bad as…
A New Era for Rare Earths: American Rare Earths Limited Secures Facility in Wyoming Exciting News for American Rare Earths Limited In a recent press release, American Rare Earths Limited (ARR) has announced a major milestone in their operations. Their subsidiary, Wyoming Rare (USA) Inc., has successfully secured a facility at the Western Research Institute…
